The BioCanRx network is changing the face of cancer treatment
BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer. We will do this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life. Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.
World Cancer Day 2020
A Message from Dr. John Bell, Scientific Director and Dr. Stéphanie Michaud, President & CEO BioCanRx
Learn more →
Successful Fourth Summit for Cancer Immunotherapy
From October 20 to 23, 2019, the Summit for Cancer Immunotherapy brought together 300 delegates including leading scientists, clinicians, trainees, economists and representatives from industry, patient groups, charities and government.
Learn more →
Both Sides of the Learning Institute Experience
The third BioCanRx-Cancer Stakeholder Alliance Learning Institute took place at this year’s Summit for Cancer Immunotherapy. This initiative brought together patient/caregiver leaders and Highly Qualified Personnel in an interactive and collaborative knowledge exchange program.
Learn more →
Join the BioCanRx Network at the 5th annual Summit for Cancer Immunotherapy (Summit4CI) in Montréal!
November 7-9, 2020
Fairmont The Queen Elizabeth Hotel
